Table 3.
Mean difference in top principal component (PC) scores for targeted metabolites by OGTT time points at early (n = 29), mid-pregnancy (n = 18), and all oral glucose tolerance tests (OGTT) combined (n = 47) 1.
| Fasting | 30 min | 60 min | 120 min | ||||
|---|---|---|---|---|---|---|---|
| β (SE) | p Value | β (SE) | p Value | β (SE) | p Value | ||
| Early pregnancy | |||||||
| PC1 | Ref. | −1.9 (0.7) | 0.005 | −5.8 (0.7) | <0.001 | −9.4 (0.7) | <0.001 |
| PC2 | Ref. | −0.9 (0.7) | 0.24 | −1.8 (0.7) | 0.02 | −1.4 (0.7) | 0.05 |
| Mid-Pregnancy | |||||||
| PC1 | Ref. | - | - | −4.7 (1.0) | <0.001 | −7.7 (1.0) | <0.001 |
| PC2 | Ref. | - | - | 0.9 (0.8) | 0.29 | 1.6 (0.8) | 0.06 |
| Early and Mid-Pregnancy | |||||||
| PC1 | Ref. | −1.2 (0.6) | 0.04 | −5.4 (0.5) | <0.001 | −8.8 (0.5) | <0.001 |
| PC2 | Ref. | 0.1 (0.6) | 0.85 | 0.8 (0.5) | 0.10 | 0.3 (0.5) | 0.60 |
1 PC’s were derived from the 65 candidate metabolites measured during the OGTTs for all participants (metabolite levels at fasting and 30, 60, and 120 min post OGTT).